Hepatitis A Fact Sheet
Bloodborne Pathogens
Section
Cause
- Hepatitis A virus (HAV)
- Non-enveloped virus of the Picornoviridae family
- One serotype identified
- Identified in 1972
- HAV is an enteric viral infection, generally transmitted
through a fecal-oral route.
Clinical Characteristics
Incubation
Period |
From 15-50 days,
average 28-30 days |
Acute Illness |
Can cause a renewed illness up to
one year after initial infection. This can happen in about 15% of
patients. |
Chronic Infection |
People usually do not remain
infected for life. The body will most often fight off the virus
naturally. |
Global Incidence |
1.5 million cases each year. |
Global Prevalence |
15-100% in various parts of the
world. |
Recovering from a Hepatitis A (Hep A) infection results in
lifelong immunity that will protect you from getting Hep A
again.
Signs and Symptoms
- Jaundice (yellowing of the skin and eyes), other general
symptoms such as uneasiness, loss of appetite, pain in the stomach
area, dark urine and fatigue.
- Most people mild to serious Hep A recover naturally.
Modes of Transmission
- Exposure to water or food products contaminated with HAV (feces
containing the virus)
- Transmission through household or sexual contact is seen as a
very rare event, particularly in heterosexual relationships
- Transmission through blood does not happen often.
Persons at Risk
Persons |
Level of
Risk |
People in the food handling industry exposed
to contaminated food or water |
High |
People who inject drugs |
Medium |
People living, visiting or working in
developing countries |
Medium |
Inmates in prisons or jails |
Medium |
Household contacts of HAV individuals |
Medium |
Hemophiliacs |
Low |
Individuals with long-term liver disease may be at higher risk
for a more serious hepatitis infection.
Prevention
- A vaccine to protect against HAV is available. A combination
vaccine for Hep A and B is also available.
Treatment
- There is no effective treatment to date. People generally
recover from symptoms in 4 to 6 weeks.
Canadian Data on the trends of HAV
- The incidence of Hep A was approximately 2.9 cases for every
100,000 persons in 1999 (Health Canada, Notifiable Diseases
Online)
Reference: Bloodborne Pathogens Section, Blood Safety
Surveillance and Health Care Acquired Infections Division, Health
Canada, 2003
To share this page just click on the social network icon of your choice.